SPY334.33+2.22 0.67%
DIA273.90+1.90 0.70%
IXIC11,108.07+109.67 1.00%

CLSA Initiates Coverage On Hutchison China Meditech with Buy Rating

CLSA initiates coverage on Hutchison China Meditech (NASDAQ:HCM) with a Buy rating.

Benzinga · -

CLSA initiates coverage on Hutchison China Meditech (NASDAQ:HCM) with a Buy rating.